BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 34299101)

  • 21. A Dissection of Oligomerization by the TRIM28 Tripartite Motif and the Interaction with Members of the Krab-ZFP Family.
    Sun Y; Keown JR; Black MM; Raclot C; Demarais N; Trono D; Turelli P; Goldstone DC
    J Mol Biol; 2019 Jun; 431(14):2511-2527. PubMed ID: 31078555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19.
    Poma AM; Basolo A; Bonuccelli D; Proietti A; Macerola E; Ugolini C; Torregrossa L; Alì G; Giannini R; Vignali P; Santini F; Toniolo A; Basolo F
    Thyroid; 2021 Dec; 31(12):1766-1775. PubMed ID: 34541878
    [No Abstract]   [Full Text] [Related]  

  • 23. Type I and III interferons are good markers to monitor COVID-19 pathophysiology.
    Darif D; Ejghal R; Desterke C; Outlioua A; Hammi I; Lemrani M; Hilali F; Guessous F; Zaid Y; Akarid K
    Cytokine; 2023 May; 165():156172. PubMed ID: 36924609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
    Chang CY; Liu HM; Chang MF; Chang SC
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.
    Galani IE; Rovina N; Lampropoulou V; Triantafyllia V; Manioudaki M; Pavlos E; Koukaki E; Fragkou PC; Panou V; Rapti V; Koltsida O; Mentis A; Koulouris N; Tsiodras S; Koutsoukou A; Andreakos E
    Nat Immunol; 2021 Jan; 22(1):32-40. PubMed ID: 33277638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type I and III interferon responses in SARS-CoV-2 infection.
    Kim YM; Shin EC
    Exp Mol Med; 2021 May; 53(5):750-760. PubMed ID: 33953323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2.
    Wang Y; Fan Y; Huang Y; Du T; Liu Z; Huang D; Wang Y; Wang N; Zhang P
    Cell Signal; 2021 Sep; 85():110064. PubMed ID: 34146659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients.
    Balestrieri E; Minutolo A; Petrone V; Fanelli M; Iannetta M; Malagnino V; Zordan M; Vitale P; Charvet B; Horvat B; Bernardini S; Garaci E; di Francesco P; Sinibaldi Vallebona P; Sarmati L; Grelli S; Andreoni M; Perron H; Matteucci C
    EBioMedicine; 2021 Apr; 66():103341. PubMed ID: 33867312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
    Oh SJ; Shin OS
    Cells; 2021 Mar; 10(3):. PubMed ID: 33801464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interferon landscape along the respiratory tract impacts the severity of COVID-19.
    Sposito B; Broggi A; Pandolfi L; Crotta S; Clementi N; Ferrarese R; Sisti S; Criscuolo E; Spreafico R; Long JM; Ambrosi A; Liu E; Frangipane V; Saracino L; Bozzini S; Marongiu L; Facchini FA; Bottazzi A; Fossali T; Colombo R; Clementi M; Tagliabue E; Chou J; Pontiroli AE; Meloni F; Wack A; Mancini N; Zanoni I
    Cell; 2021 Sep; 184(19):4953-4968.e16. PubMed ID: 34492226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy.
    Pan D; Bao X; Hu M; Jiao M; Li F; Li CY
    Cancer Res; 2022 Aug; 82(15):2748-2760. PubMed ID: 35648422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity.
    Petrone V; Fanelli M; Giudice M; Toschi N; Conti A; Maracchioni C; Iannetta M; Resta C; Cipriani C; Miele MT; Amati F; Andreoni M; Sarmati L; Rogliani P; Novelli G; Garaci E; Rasi G; Sinibaldi-Vallebona P; Minutolo A; Matteucci C; Balestrieri E; Grelli S
    Front Microbiol; 2023; 14():1155624. PubMed ID: 37283924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
    Metz-Zumaran C; Kee C; Doldan P; Guo C; Stanifer ML; Boulant S
    J Virol; 2022 Apr; 96(7):e0170521. PubMed ID: 35262371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells.
    Januszkiewicz-Lewandowska D; Nowicka K; Rembowska J; Fichna M; Żurawek M; Derwich K; Nowak J
    Acta Haematol; 2013; 129(4):232-7. PubMed ID: 23328642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Endogenous Retrovirus (HERV) Transcriptome Is Dynamically Modulated during SARS-CoV-2 Infection and Allows Discrimination of COVID-19 Clinical Stages.
    Grandi N; Erbì MC; Scognamiglio S; Tramontano E
    Microbiol Spectr; 2023 Feb; 11(1):e0251622. PubMed ID: 36602345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Endogenous Retroviruses as Gene Expression Regulators: Insights from Animal Models into Human Diseases.
    Durnaoglu S; Lee SK; Ahnn J
    Mol Cells; 2021 Dec; 44(12):861-878. PubMed ID: 34963103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING.
    Karlowitz R; Stanifer ML; Roedig J; Andrieux G; Bojkova D; Bechtel M; Smith S; Kowald L; Schubert R; Boerries M; Cinatl J; Boulant S; van Wijk SJL
    Cell Death Dis; 2022 Aug; 13(8):684. PubMed ID: 35933402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms.
    Giménez-Orenga K; Pierquin J; Brunel J; Charvet B; Martín-Martínez E; Perron H; Oltra E
    Front Immunol; 2022; 13():1020064. PubMed ID: 36389746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Human Endogenous Retroviruses in Systemic Lupus Erythematosus: Multiomic Integration With Gene Expression.
    Stearrett N; Dawson T; Rahnavard A; Bachali P; Bendall ML; Zeng C; Caricchio R; Pérez-Losada M; Grammer AC; Lipsky PE; Crandall KA
    Front Immunol; 2021; 12():661437. PubMed ID: 33986751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.